For patients with atrial fibrillation (AFib), new hope is here at Bayhealth. We offer two new minimally invasive treatment options: left atrial appendage closure (LAAC) with the groundbreaking WATCHMAN FLX™ device and left-sided cardiac ablations.
The WATCHMAN is the only FDA-approved device proven to reduce stroke risk in patients with non-valvular AFib. Produced by Boston Scientific, it is the most studied and implanted (LAAC) device in the world. It is implanted through a standard percutaneous technique. More than 90 percent of all stroke-causing clots coming from the heart form in the LAA. The new design of this next-generation technology ensures the best long-term outcomes.
View the video below and download the clinical data and safety statistics to better understand how the WATCHMAN procedure can benefit your patients.
If you have a patient with AFib who may be a candidate for the WATCHMAN, please refer them electronically though Epic to Bayhealth Interventional Cardiologist Manjeet Singh, DO or call the WATCHMAN referral line today at 302-744-7684.
Depending on the patient’s circumstances, another non-surgical option is the left-sided cardiac ablation. This can correct the arrhythmia and reduce stroke risk while allowing a patient to avoid the lifelong use of blood thinners. For cardiac ablations, please refer patients to Bayhealth Electrophysiologist Raymond E. Miller, MD.